X Zhang, H Xing, Y Zhao, Z Ma - Pharmaceutics, 2018 - mdpi.com
Over the past decades, a large number of drugs as well as drug candidates with poor dissolution characteristics have been witnessed, which invokes great interest in enabling …
Cilostazol (CLZ) is an antiplatelet agent with limited solubility (∼ 6 μg/ml at 25° C), poor absorption and low oral bioavailability. In this study, solid lipid nanoparticles (SLNs) were …
Abstract We, the Editors and Publisher of Drug Delivery have retracted the following article: Sultan Alshehri, Syed Sarim Imam, Afzal Hussain, Mohammad A. Altamimi, Nabil K …
Background. Chemotherapeutic drugs cause severe toxicities if administered unprotected, without proper targeting, and controlled release. In this study, we developed topotecan‐(TPT …
As a neglected tropical disease, Leishmaniasis is significantly instigating morbidity and mortality across the globe. Its clinical spectrum varies from ulcerative cutaneous lesions to …
M Khatoon, KU Shah, FU Din, SU Shah… - Drug …, 2017 - Taylor & Francis
Vesicular drug delivery systems have gained wide attention in the field of nanotechnology. Among them proniosomes become the superior over other vesicular carriers. Proniosomes …
F ud Din, A Zeb, KU Shah - Journal of drug delivery science and …, 2019 - Elsevier
This study aims to develop ezetimibe-loaded solid lipid nanoparticles (SLNs) and compare them with marketed product and drug suspension for dissolution and bioavailability …
S Maqsood, FU Din, SU Khan, E Elahi, Z Ali… - Life Sciences, 2022 - Elsevier
Aims Herein, we investigate the potential of levosulpiride-loaded nanostructured lipid carriers (LEVO-NLCs) for effective brain delivery with anti-psychotic and antidepressant …
This research was designed to identify thermodynamically and kinetically stable lipidic self- emulsifying formulations through simple energy dynamics in addition to highlighting and …